IB 
Union Calendar 114
108TH CONGRESS 
1ST SESSION H. R. 2086
[Report No. 108–167, Parts I and II] 
To reauthorize the Office of National Drug Control Policy. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 14, 2003
Mr. SOUDER (for himself and Mr. TOM DAVIS of Virginia) introduced the fol-
lowing bill; which was referred to the Committee on Government Reform, 
and in addition to the Committees on the Judiciary, Energy and Com-
merce, and Select Intelligence (Permanent Select), for a period to be sub-
sequently determined by the Speaker, in each case for consideration of 
such provisions as fall within the jurisdiction of the committee concerned 
JUNE 19, 2003
Reported from the Committee on Government Reform with an amendment 
[Strike out all after the enacting clause and insert the part printed in italic] 
JUNE 19, 2003
Referral to the Committees on the Judiciary, Energy and Commerce, and the 
Permanent Select Committee on Intelligence extended for a period ending 
not later than July 14, 2003
JULY 14, 2003
Reported from the Committee on the Judiciary with an amendment 
[Strike out all after the enacting clause and insert the part printed in boldface roman] 
JULY 14, 2003
Committee on Energy and Commerce, and the Permanent Select Committee 
on Intelligence discharged; committed to the Committee of the Whole 
House on the State of the Union and ordered to be printed
[For text of introduced bill, see copy of bill as introduced on May 14, 2003] 
A BILL 
To reauthorize the Office of National Drug Control Policy.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE; REFERENCES; TABLE OF CON-
TENTS. 
(a) SHORT TITLE.—This Act may be cited as the ‘‘Of-
fice of National Drug Control Policy Reauthorization Act 
of 2003’’. 
(b) AMENDMENT OF OFFICE OF NATIONAL DRUG CON-
TROL POLICY REAUTHORIZATION ACT OF 1998.—Except as 
otherwise expressly provided, whenever in this Act an 
amendment or repeal is expressed in terms of an amend-
ment to, or repeal of, a section or other provision, the ref-
erence shall be considered to be made to a section or other 
provision of the Office of National Drug Control Policy Re-
authorization Act of 1998 (Public Law 105–277; 21 U.S.C. 
1701 et seq.). 
(c) TABLE OF CONTENTS.—The table of contents of this 
Act is as follows:
Sec. 1. Short title; references; table of contents. 
Sec. 2. Amendments to definitions. 
Sec. 3. Amendments relating to appointment and duties of Director and Deputy 
Directors. 
Sec. 4. Amendments relating to coordination with other agencies.
Sec. 5. Development, submission, implementation, and assessment of National 
Drug Control Strategy. 
Sec. 6. High intensity drug trafficking areas program. 
Sec. 7. Funding for certain high intensity drug trafficking areas. 
Sec. 8. Amendments relating to Counter-Drug Technology Assessment Center. 
Sec. 9. Repeals. 
Sec. 10. National Youth Antidrug Media Campaign. 
Sec. 11. Authorization of appropriations. 
Sec. 12. Extension of termination date.
SEC. 2. AMENDMENTS TO DEFINITIONS. 
(a) AMENDMENTS TO DEFINITIONS.—Section 702 (21 
U.S.C. 1701) is amended—
(1) in paragraph (1)—
(A) by striking ‘‘and’’ at the end of sub-
paragraph (F); 
(B) by striking the period at the end of sub-
paragraph (G) and inserting a semicolon; and 
(C) by adding at the end the following: 
‘‘(H) interventions for drug abuse and de-
pendence; and 
‘‘(I) international drug control coordination 
and cooperation with respect to activities de-
scribed in this paragraph.’’. 
(2) in paragraph (9), by striking ‘‘implicates’’ 
and inserting ‘‘indicates’’; 
(3) in paragraph (10)—
(A) by striking ‘‘and’’ at the end of sub-
paragraph (B); 
(B) by striking the period at the end of sub-
paragraph (C) and inserting ‘‘; and’’; and
(C) by adding at the end the following: 
‘‘(D) domestic drug law enforcement, in-
cluding law enforcement directed at drug users.’’; 
and 
(4) in paragraph (11)—
(A) by inserting before the semicolon in sub-
paragraph (A) the following: ‘‘(including source 
country programs, and law enforcement outside 
the United States)’’; 
(B) by inserting ‘‘and’’ after the semicolon 
in subparagraph (B); 
(C) by striking ‘‘; and’’ at the end of sub-
paragraph (C) and inserting a period; and 
(D) by striking subparagraph (D). 
(b) CONFORMING AMENDMENTS.—Section 703(b)(3) 
(21 U.S.C. 1702(b)(3)) is amended—
(1) in subparagraph (A), by striking ‘‘(G)’’ and 
inserting ‘‘(H)’’; and 
(2) in subparagraph (C)—
(A) by striking ‘‘(C)’’ and inserting ‘‘(D)’’; 
and 
(B) by striking ‘‘and subparagraph (D) of 
section 702(11)’’.
SEC. 3. AMENDMENTS RELATING TO APPOINTMENT AND 
DUTIES OF DIRECTOR AND DEPUTY DIREC-
TORS. 
(a) DESIGNATION
OF OTHER OFFICERS.—Section 
704(a)(3) (21 U.S.C. 1703(a)(3)) is amended—
(1) by striking ‘‘permanent employee’’ and in-
serting ‘‘officer or employee’’; and 
(2) by striking ‘‘serve as the Director’’ and in-
serting ‘‘serve as the acting Director’’. 
(b) RESPONSIBILITIES OF DIRECTOR.—Section 704(b) 
(21 U.S.C. 1703(b)) is amended—
(1) in paragraph (4), by striking ‘‘Federal de-
partments and agencies engaged in drug enforce-
ment,’’ and inserting ‘‘National Drug Control Pro-
gram agencies,’’; 
(2) by inserting ‘‘and’’ at the end of paragraph 
(12); 
(3) by striking paragraphs (13) and (14); and 
(4) by redesignating paragraph (15) as para-
graph (13). 
(c) REVIEW AND CERTIFICATION OF NATIONAL DRUG 
CONTROL
PROGRAM
BUDGET.—Section 704(c)(3) (21 
U.S.C. 1703(c)(3)) is amended—
(1) by redesignating subparagraphs (C) and (D) 
as subparagraphs (D) and (E), respectively;
(2) by inserting after subparagraph (B) the fol-
lowing new subparagraph: 
‘‘(C) SPECIFIC
REQUESTS.—The Director 
shall not confirm the adequacy of any budget re-
quest that—
‘‘(i) requests funding for Federal law 
enforcement activities that do not ade-
quately compensate for transfers of drug en-
forcement resources and personnel to law 
enforcement and investigation activities not 
related to drug enforcement as determined 
by the Director; 
‘‘(ii) requests funding for law enforce-
ment activities on the borders of the United 
States that do not adequately direct re-
sources to drug interdiction and enforce-
ment as determined by the Director; 
‘‘(iii) requests funding for drug treat-
ment activities that do not provide adequate 
result and accountability measures as deter-
mined by the Director; 
‘‘(iv) requests funding for any activi-
ties of the Safe and Drug Free Schools Pro-
gram that do not include a clear antidrug
message or purpose intended to reduce drug 
use; 
‘‘(v) requests funding to enforce section 
484(r)(1) of the Higher Education Act of 
1965 (20 U.S.C. 1091(r)(1)) with respect to 
convictions for drug-related offenses not oc-
curring during a period of enrollment for 
which the student was receiving any Fed-
eral grant, loan, or work assistance; 
‘‘(vi) requests funding for drug treat-
ment activities that do not adequately sup-
port and enhance Federal drug treatment 
programs and capacity, as determined by 
the Director; or 
‘‘(vii) requests funding for fiscal year 
2005 for activities of the Department of 
Education, unless it is accompanied by a 
report setting forth a plan for providing ex-
pedited consideration of student loan appli-
cations for all individuals who submitted 
an application for any Federal grant, loan, 
or work assistance that was rejected or de-
nied pursuant to 484(r)(1) of the Higher 
Education 
Act 
of 
1965 
(20 
U.S.C. 
1091(r)(1)) by reason of a conviction for a
drug-related offense not occurring during a 
period of enrollment for which the indi-
vidual was receiving any Federal grant, 
loan, or work assistance.’’; 
(3) in subparagraph (D)(iii), as so redesignated, 
by inserting ‘‘and the authorizing committees of Con-
gress for the Office’’ after ‘‘House of Representatives’’; 
and 
(4) in subparagraph (E)(ii)(bb), as so redesig-
nated, by inserting ‘‘and the authorizing committees 
of Congress for the Office’’ after ‘‘House of Represent-
atives’’. 
(d) REPROGRAMMING AND TRANSFER REQUESTS.—
Section 704(c)(4)(A) (21 U.S.C. 1703(c)(4)(A)) is amended 
by striking ‘‘$5,000,000’’ and inserting ‘‘$1,000,000’’. 
(e) POWERS
OF
DIRECTOR.—Section 704(d) (21 
U.S.C. 1703(d)) is amended—
(1) in paragraph (8)(D), by striking ‘‘have been 
authorized by Congress;’’ and inserting ‘‘authorized 
by law;’’; 
(2) in paragraph (9)—
(A) by inserting ‘‘notwithstanding any 
other provision of law,’’ after ‘‘(9)’’; and 
(B) by striking ‘‘Strategy; and’’ and insert-
ing ‘‘Strategy and notify the authorizing Com-
mittees of Congress for the Office of any fund 
control notice issued;’’; 
(3) in paragraph (10), by striking ‘‘(22 U.S.C. 
2291j).’’ and inserting ‘‘(22 U.S.C. 2291j) and section 
706 of the Department of State Authorization Act for 
Fiscal Year 2003 (22 U.S.C. 229j–l);’’; 
(4) by adding at the end the following new para-
graphs: 
‘‘(11) not later than August 1 of each year, sub-
mit to the President a report, and transmit copies of 
the report to the Secretary of State and the author-
izing Committees of Congress for the Office, that—
‘‘(A) provides the Director’s assessment of 
which countries are major drug transit countries 
or major illicit drug producing countries as de-
fined in section 481(e) of the Foreign Assistance 
Act of 1961; 
‘‘(B) provides the Director’s assessment of 
whether each country identified under subpara-
graph (A) has cooperated fully with the United 
States or has taken adequate steps on its own to 
achieve full compliance with the goals and objec-
tives established by the United Nations Conven-
tion Against Illicit Traffic in Narcotic Drugs 
and Psychotropic Substances and otherwise has
assisted in reducing the supply of illicit drugs to 
the United States; and 
‘‘(C) provides the Director’s assessment of 
whether application of procedures set forth in 
section 490(a) through (h) of the Foreign Assist-
ance Act of 1961, as provided in section 706 of 
the Department of State Authorization Act for 
Fiscal Year 2003, is warranted with respect to 
countries the Director assesses have not cooper-
ated fully; and 
‘‘(12) appoint a United States Interdiction Coor-
dinator under subsection (i).’’. 
(f) UNITED STATES INTERDICTION COORDINATOR.—
Section 704 (21 U.S.C. 1703) is further amended by adding 
at the end the following: 
‘‘(i) UNITED STATES INTERDICTION COORDINATOR.—
‘‘(1) IN GENERAL.—There shall be in the Office 
a United States Interdiction Coordinator, who shall 
be appointed by the Director and shall perform duties 
determined by the Director with respect to coordina-
tion of efforts to interdict illicit drugs from the 
United States. 
‘‘(2) APPOINTMENT.—
‘‘(A) IN
GENERAL.—Notwithstanding any 
other provision of law (except subparagraph
(B)), the Director may appoint any individual 
to serve as the United States Interdiction Coordi-
nator. 
‘‘(B) LIMITATION.—The Director may not 
appoint to such position any individual who 
concurrently serves as the head of any other Fed-
eral department or agency or any subdivision 
thereof with responsibility for narcotics interdic-
tion activities, except the counternarcotics officer 
of the Department of Homeland Security ap-
pointed under section 878 of the Homeland Secu-
rity Act of 2002 (6 U.S.C. 458).’’. 
(g) REQUIREMENT FOR SOUTH AMERICAN HEROIN 
STRATEGY.—
(1) IN GENERAL.—Not later than 90 days after 
the date of the enactment of this Act, the Director of 
National Drug Control Policy shall submit to the 
Congress a comprehensive strategy that addresses the 
increased threat from South American heroin, and in 
particular Colombian heroin. 
(2) CONTENTS.—The strategy shall—
(A) include opium eradication efforts to 
eliminate the problem at the source to prevent it 
from reoccurring before the heroin enters the 
stream of commerce;
(B) interdiction and precursor chemical 
controls; 
(C) demand reduction and treatment; 
(D) provisions that ensure the maintenance 
at current levels of efforts to eradicate coca in 
Colombia; and 
(E) assessment of the level of additional 
funding and resources necessary to simulta-
neously address the threat from South American 
heroin and the threat from Colombian coca. 
SEC. 4. AMENDMENTS RELATING TO COORDINATION WITH 
OTHER AGENCIES. 
Section 705 (21 U.S.C. 1704) is amended—
(1) in subsection (a)(1)(A), by striking ‘‘abuse’’; 
(2) by amending paragraph (3) of subsection (a) 
to read as follows: 
‘‘(3) REQUIRED REPORTS.—
‘‘(A) SECRETARIES OF THE INTERIOR AND 
AGRICULTURE.—The Secretaries of Agriculture 
and Interior shall, by July 1 of each year, joint-
ly submit to the Director and the authorizing 
Committees of Congress for the Office an assess-
ment of the quantity of illegal drug cultivation 
and manufacturing in the United States on
lands owned or under the jurisdiction of the Fed-
eral Government for the preceding year. 
‘‘(B) ATTORNEY
GENERAL.—The Attorney 
General shall, by July 1 of each year, submit to 
the Director and the authorizing Committees of 
Congress for the Office information for the pre-
ceding year regarding the number and type of—
‘‘(i) arrests for drug violations; 
‘‘(ii) prosecutions for drug violations 
by United States Attorneys; and 
‘‘(iii) the number and type of seizures 
of drugs by each component of the Depart-
ment seizing drugs, as well as statistical in-
formation on the geographic areas of such 
seizures. 
‘‘(C) SECRETARY
OF
HOMELAND
SECU-
RITY.—The Secretary of Homeland Security 
shall, by July 1 of each year, submit to the Di-
rector and the authorizing Committees of Con-
gress for the Office information for the preceding 
year regarding—
‘‘(i) the number and type of seizures of 
drugs by each component of the Department 
seizing drugs, as well as statistical informa-
tion on the geographic areas of such sei-
zures; and 
‘‘(ii) the number of air and maritime 
patrol hours undertaken by each component 
of the Department primarily dedicated to 
drug supply reduction missions. 
‘‘(D) SECRETARY OF DEFENSE.—The Sec-
retary of Defense shall, by July 1 of each year, 
submit to the Director and the authorizing Com-
mittees of Congress for the Office information for 
the preceding year regarding the number of air 
and maritime patrol hours primarily dedicated 
to drug supply reduction missions undertaken by 
each component of the Department of Defense.’’; 
and 
(3) in subsection (b)(2)(B), by striking ‘‘Pro-
gram.’’ and inserting ‘‘Strategy.’’. 
SEC. 5. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
Section 706 (21 U.S.C. 1705) is amended to read as 
follows:
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVELOP-
MENT
AND SUBMISSION
OF NATIONAL DRUG CONTROL 
STRATEGY.—
‘‘(1) IN GENERAL.—Not later than February 1 of 
each year, the President shall submit to Congress a 
National Drug Control Strategy, which shall set forth 
a comprehensive plan for reducing illicit drug use 
and the consequences of illicit drug use in the United 
States by reducing the demand for illegal drugs, lim-
iting the availability of illegal drugs, and conducting 
law enforcement activities with respect to illegal 
drugs. 
‘‘(2) CONTENTS.— 
‘‘(A) IN
GENERAL.—The National Drug 
Control Strategy submitted under paragraph (1) 
shall include—
‘‘(i) 
comprehensive, 
research-based, 
long-range, and quantifiable goals for re-
ducing illicit drug use and the consequences 
of illicit drug use in the United States; 
‘‘(ii) annual objectives and strategy for 
demand reduction, supply reduction, and 
law enforcement activities, specific targets
to accomplish long-range quantifiable reduc-
tion in illicit drug use as determined by the 
Director, and specific measurements to 
evaluate progress toward the targets and 
strategic goals; 
‘‘(iii) a strategy to reduce the avail-
ability and purity of illegal drugs and the 
level of drug-related crime in the United 
States; 
‘‘(iv) an assessment of Federal effec-
tiveness in achieving the National Drug 
Control Strategy for the previous year, in-
cluding—
‘‘(I) a specific evaluation of 
whether the objectives and targets for 
reducing illicit drug use for the pre-
vious year were met and reasons for 
the success or failure of the previous 
year’s Strategy; and 
‘‘(II) an assessment of the avail-
ability and purity of illegal drugs and 
the level of drug-related crime in the 
United States; 
‘‘(v) notification of any program or 
budget priorities that the Director expects to
significantly change from the current Strat-
egy over the next five years; 
‘‘(vi) a review of international, State, 
local, and private sector drug control activi-
ties to ensure that the United States pursues 
well-coordinated and effective drug control 
at all levels of government; 
‘‘(vii) such statistical data and infor-
mation as the Director deems appropriate 
to demonstrate and assess trends relating to 
illicit drug use, the effects and consequences 
thereof, supply reduction, demand reduc-
tion, drug-related law enforcement, and the 
implementation of the National Drug Con-
trol Strategy; and 
‘‘(viii) a supplement reviewing the ac-
tivities of each individual National Drug 
Control Program agency during the pre-
vious year with respect to the National 
Drug Control Strategy and the Director’s 
assessment of the progress of each National 
Drug Control Program agency in meeting 
its responsibilities under the National Drug 
Control Strategy.
‘‘(B) CLASSIFIED INFORMATION.—Any con-
tents of the National Drug Control Strategy that 
involve information properly classified under 
criteria established by an Executive order shall 
be presented to Congress separately from the rest 
of the National Drug Control Strategy. 
‘‘(C) SELECTION OF DATA AND INFORMA-
TION.—In selecting data and information for in-
clusion under subparagraph (A), the Director 
shall ensure—
‘‘(i) the inclusion of data and informa-
tion that will permit analysis of current 
trends against previously compiled data 
and information where the Director believes 
such analysis enhances long-term assessment 
of the National Drug Control Strategy; and 
‘‘(ii) the inclusion of data and infor-
mation to permit a standardized and uni-
form assessment of the effectiveness of drug 
treatment programs in the United States. 
‘‘(3) PROCESS FOR DEVELOPMENT AND SUBMIS-
SION.—
‘‘(A) CONSULTATION.—In developing and 
effectively implementing the National Drug Con-
trol Strategy, the Director—
‘‘(i) shall consult with—
‘‘(I) the heads of the National 
Drug Control Program agencies; 
‘‘(II) Congress; 
‘‘(III) State and local officials; 
‘‘(IV) private citizens and organi-
zations with experience and expertise 
in demand reduction; 
‘‘(V) private citizens and organi-
zations with experience and expertise 
in supply reduction; 
‘‘(VI) private citizens and organi-
zations with experience and expertise 
in law enforcement; and 
‘‘(VII) appropriate representatives 
of foreign governments; 
‘‘(ii) with the concurrence of the Attor-
ney General, may require the El Paso Intel-
ligence Center to undertake specific tasks or 
projects to implement the National Drug 
Control Strategy; 
‘‘(iii) with the concurrence of the Di-
rector of Central Intelligence and the Attor-
ney General, may request that the National 
Drug Intelligence Center undertake specific
tasks or projects to implement the National 
Drug Control Strategy; and 
‘‘(iv) may make recommendations to 
the Secretary of Health and Human Serv-
ices on research that supports or advances 
the National Drug Control Strategy. 
‘‘(B) 
RECOMMENDATIONS.—Recommenda-
tions under subparagraph (A)(iv) may include 
recommendations of research to be performed at 
the National Institutes of Health, including the 
National Institute on Drug Abuse, or any other 
appropriate agency within the Department of 
Health and Human Services. 
‘‘(C) INCLUSION
IN
STRATEGY.—The Na-
tional Drug Control Strategy under this sub-
section shall include a list of each entity con-
sulted under subparagraph (A)(i). 
‘‘(4) SUBMISSION OF REVISED STRATEGY.—The 
President may submit to Congress a revised National 
Drug Control Strategy that meets the requirements of 
this section—
‘‘(A) at any time, upon a determination by 
the President, in consultation with the Director, 
that the National Drug Control Strategy in effect 
is not sufficiently effective; or
‘‘(B) if a new President or Director takes 
office. 
‘‘(b) PERFORMANCE MEASUREMENT SYSTEM.—Not 
later than February 1 of each year, the Director shall sub-
mit to Congress a description of the national drug control 
performance measurement system, designed in consultation 
with affected National Drug Control Program agencies, that 
includes performance measures for the National Drug Con-
trol Strategy and activities of National Drug Control Pro-
gram agencies related to the National Drug Control Strat-
egy.’’. 
SEC. 6. HIGH INTENSITY DRUG TRAFFICKING AREAS PRO-
GRAM. 
(a) IN GENERAL.—Section 707 (21 U.S.C. 1706) is 
amended to read as follows: 
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
‘‘(a) ESTABLISHMENT.—There is established in the Of-
fice a program to be known as the High Intensity Drug 
Trafficking Areas Program (in this section referred to as 
the ‘Program’). 
‘‘(b) PURPOSES.—The purposes of the Program are the 
following: 
‘‘(1) To reduce drug availability and facilitate 
cooperative efforts between Federal, State, and local
law enforcement agencies in areas with significant 
drug trafficking problems that harmfully impact other 
parts of the Nation. 
‘‘(2) To provide assistance to agencies to come 
together to assess regional threats, design coordinated 
strategies to combat those threats, share intelligence, 
and develop and implement coordinated initiatives to 
implement the strategies. 
‘‘(c) DESIGNATION.—The Director, upon consultation 
with the Attorney General, the Secretary of the Treasury, 
the Secretary of Homeland Security, heads of the National 
Drug Control Program agencies, and the Governor of each 
applicable State, may designate any specified area of the 
United States as a high intensity drug trafficking area. 
‘‘(d) FACTORS FOR CONSIDERATION.—
‘‘(1) IN GENERAL.—In considering whether to 
designate an area under this section as a high inten-
sity drug trafficking area, the Director shall consider, 
in addition to such other criteria as the Director con-
siders to be appropriate, the extent to which—
‘‘(A) the area is a major center of illegal 
drug production, manufacturing, importation, or 
distribution for the United States as compared to 
other areas of the United States;
‘‘(B) State and local law enforcement agen-
cies have committed resources to respond to the 
drug trafficking problem in the area, thereby in-
dicating a determination to respond aggressively 
to the problem; 
‘‘(C) drug-related production, manufac-
turing, importation, or distribution in the area 
is having a significant harmful impact in other 
areas of the United States; and 
‘‘(D) a significant increase in allocation of 
Federal resources is necessary to respond ade-
quately to drug-related activities in the area. 
‘‘(2) CONSIDERATIONS.—For purposes of para-
graph (1)(A), in considering whether an area is a 
major center of illegal drug production, manufac-
turing, importation, or distribution as compared to 
other areas of the United States, the Director shall 
consider—
‘‘(A) the quantity of illicit drug traffic en-
tering or transiting the area originating in for-
eign countries; 
‘‘(B) the quantity of illicit drugs produced 
in the area;
‘‘(C) the number of Federal, State, and local 
arrests, prosecutions, and convictions for drug 
trafficking and distribution offenses in the area; 
‘‘(D) the degree to which the area is a center 
for the activities of national drug trafficking or-
ganizations; and 
‘‘(E) such other criteria as the Director con-
siders appropriate. 
‘‘(e) SOUTHWEST BORDER.—The Director may not 
designate any county contiguous to the international land 
border with Mexico as part of any high intensity drug traf-
ficking area other than as part of a single Southwest Border 
high intensity drug trafficking area. 
‘‘(f) REMOVAL FROM DESIGNATION.—The Director 
may remove an area or portion of an area from designation 
as a high intensity drug trafficking area under this section 
upon determination that the area or portion of an area no 
longer is a high intensity drug trafficking area, considering 
the factors in subsections (d) and (e) in addition to such 
other criteria as the Director considers to be appropriate. 
‘‘(g) AUTHORITY OF THE DIRECTOR.—After making 
such a designation and in order to provide Federal assist-
ance to the area so designated, the Director may—
‘‘(1) obligate such sums as appropriated for the 
Program, in accordance with subsection (h);
‘‘(2) direct the temporary reassignment of Fed-
eral personnel to such area, subject to the approval of 
the head of the department or agency that employs 
such personnel; and 
‘‘(3) take any other action authorized under sec-
tion 704 to provide increased Federal assistance to 
those areas. 
‘‘(h) ALLOCATION OF FUNDING.—In obligating sums 
appropriated for the Program, the Director shall comply 
with the following: 
‘‘(1) 30 PERCENT
SET
ASIDE.—The Director 
shall expend no less than 30 percent of the amounts 
appropriated under this section in the seven high in-
tensity drug trafficking areas (excluding the South-
west Border high intensity drug trafficking area) for 
which the Director determines that Program activities 
with respect to such areas will have the greatest im-
pact on reducing overall drug traffic in the United 
States. 
‘‘(2) 25 PERCENT
SET
ASIDE.—The Director 
shall expend no less than 25 percent of the amounts 
appropriated under this section in nine other high in-
tensity drug trafficking areas (excluding the South-
west Border high intensity drug trafficking area) for 
which the Director determines that Program activities
with respect to such areas will have the next greatest 
impact on reducing overall drug traffic in the United 
States. 
‘‘(3) SOUTHWEST BORDER AREA.—
‘‘(A) 20 PERCENT SET ASIDE.—The Direc-
tor shall expend no less than 20 percent of the 
amounts appropriated under this section in the 
Southwest Border high intensity drug trafficking 
area. 
‘‘(B) REALLOCATION
WITHIN
AREA.—The 
executive committee of the Southwest Border high 
intensity drug trafficking area may reallocate up 
to five percent of the total funds allocated to that 
area among its components, with the approval of 
the Director. 
‘‘(4) REMAINING AREAS.—The Director shall ex-
pend no less than 10 percent of the amounts appro-
priated under this section in the remaining high in-
tensity drug trafficking areas. 
‘‘(5) DISCRETIONARY EXPENDITURES.—
‘‘(A) IN
GENERAL.—In addition to the 
amounts allocated under paragraphs (1) through 
(4) the Director may expend 15 percent of the 
amounts appropriated under this section on a 
discretionary basis.
‘‘(B) CONSIDERATION OF IMPACT.—In allo-
cating funds under this paragraph, the Director 
shall consider—
‘‘(i) the impact of activities funded on 
reducing overall drug traffic in the United 
States; 
‘‘(ii) performance measures of effective-
ness; and 
‘‘(iii) such other criteria as the Direc-
tor considers appropriate. 
‘‘(i) USE OF FUNDS.—
‘‘(1) LIMITATION.—No funds appropriated for 
the Program shall be expended for drug prevention or 
drug treatment programs. 
‘‘(2) LIMITATION ON APPLICABILITY.—Paragraph 
(1) shall not apply with respect to the Baltimore/
Washington high intensity drug trafficking area. 
‘‘(j) TERRORISM ACTIVITIES.—
‘‘(1) ASSISTANCE
AUTHORIZED.—The Director 
may authorize use of resources available for the Pro-
gram to assist Federal, State, and local law enforce-
ment agencies in investigations and activities related 
to terrorism and prevention of terrorism, especially 
but not exclusively where such investigations are re-
lated to drug trafficking.
‘‘(2) LIMITATION.—The Director shall ensure—
‘‘(A) that assistance provided under para-
graph (1) remains incidental to the purpose of 
the Program to reduce drug availability and 
carry out drug-related law enforcement activi-
ties; and 
‘‘(B) that significant resources of the Pro-
gram are not redirected to activities exclusively 
related to terrorism. 
‘‘(k) BOARD REPRESENTATION.—None of the funds ap-
propriated under this section may be expended for any high 
intensity drug trafficking area, or for a partnership under 
the Program, if the executive board or equivalent governing 
committee with respect to such area or partnership is not 
comprised of equal voting representation between represent-
atives of Federal law enforcement agencies and representa-
tives of State and local law enforcement agencies. 
‘‘(l) ROLE
OF DRUG ENFORCEMENT ADMINISTRA-
TION.—The Director, in consultation with the Attorney 
General, shall ensure that a representative of the Drug En-
forcement Administration is included in the Intelligence 
Support Center for each high intensity drug trafficking 
area.
‘‘(m) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to the Office of National 
Drug Control Policy to carry out this section—
‘‘(1) $230,000,000 for fiscal year 2004; 
‘‘(2) $240,000,000 for each of fiscal years 2005 
and 2006; and 
‘‘(3) $250,000,000 for each of fiscal years 2007 
and 2008.’’. 
(b) REVIEW OF CURRENT AREAS.—Within one year 
after the date of enactment of this Act, the Director of Na-
tional Drug Control Policy shall—
(1) review each of the areas currently designated 
as a high intensity drug trafficking area to determine 
whether it continues to warrant designation as a high 
intensity drug trafficking area, considering the fac-
tors in section 707(d) of the Office of National Drug 
Control Policy Reauthorization Act of 1998, as 
amended by this section, in addition to such other 
criteria as the Director considers to be appropriate; 
and 
(2) terminate such description for an area or 
portion of an area determined to no longer warrant 
designation.
SEC. 7. FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS. 
(a) SHORT TITLE.—This section may be cited as the 
‘‘Dawson Family Community Protection Act’’. 
(b) FINDINGS.—Congress finds the following: 
(1) In the early morning hours of October 16, 
2002, the home of Carnell and Angela Dawson was 
firebombed in apparent retaliation for Mrs. Dawson’s 
notification of police about persistent drug distribu-
tion activity in their East Baltimore City neighbor-
hood. 
(2) The arson claimed the lives of Mr. and Mrs. 
Dawson and their 5 young children, aged 9 to 14. 
(3) The horrific murder of the Dawson family is 
a stark example of domestic narco-terrorism. 
(4) In all phases of counter-narcotics law en-
forcement—from prevention to investigation to pros-
ecution to reentry—the voluntary cooperation of ordi-
nary citizens is a critical component. 
(5) Voluntary cooperation is difficult for law en-
forcement officials to obtain when citizens feel that co-
operation carries the risk of violent retaliation by ille-
gal drug trafficking organizations and their affiliates. 
(6) Public confidence that law enforcement is 
doing all it can to make communities safe is a pre-
requisite for voluntary cooperation among people who 
may be subject to intimidation or reprisal (or both). 
(7) Witness protection programs are insufficient 
on their own to provide security because many indi-
viduals and families who strive every day to make 
distressed neighborhoods livable for their children, 
other relatives, and neighbors will resist or refuse of-
fers of relocation by local, State, and Federal prosecu-
torial agencies and because, moreover, the continued 
presence of strong individuals and families is critical 
to preserving and strengthening the social fabric in 
such communities. 
(8) Where (as in certain sections of Baltimore 
City) interstate trafficking of illegal drugs has severe 
ancillary local consequences within areas designated 
as high intensity drug trafficking areas, it is impor-
tant that supplementary High Intensity Drug Traf-
ficking Areas Program funds be committed to support 
initiatives aimed at making the affected communities 
safe for the residents of those communities and en-
couraging their cooperation with local, State, and 
Federal law enforcement efforts to combat illegal drug 
trafficking. 
(c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS.—Section 707 (21 U.S.C. 1706) is
further amended in subsection (h) by adding at the end the 
following new paragraph: 
‘‘(6) SPECIFIC PURPOSES.—
‘‘(A) IN GENERAL.—The Director shall en-
sure that, of the amounts appropriated for a fis-
cal year for the Program, at least $1,000,000 is 
used in high intensity drug trafficking areas 
with severe neighborhood safety and illegal drug 
distribution problems. 
‘‘(B) REQUIRED
USES.—The funds used 
under subparagraph (A) shall be used—
‘‘(i) to ensure the safety of neighbor-
hoods and the protection of communities, 
including the prevention of the intimidation 
of potential witnesses of illegal drug dis-
tribution and related activities; and 
‘‘(ii) to combat illegal drug trafficking 
through such methods as the Director con-
siders appropriate, such as establishing or 
operating (or both) a toll-free telephone hot-
line for use by the public to provide infor-
mation about illegal drug-related activi-
ties.’’.
SEC. 8. AMENDMENTS RELATING TO COUNTER-DRUG TECH-
NOLOGY ASSESSMENT CENTER. 
(a) CHIEF SCIENTIST.—Section 708(b) (21 U.S.C. 
1707(b)) is amended—
(1) in the heading by striking ‘‘DIRECTOR OF 
TECHNOLOGY.—’’ 
and 
inserting 
‘‘CHIEF
SCI-
ENTIST.—’’; and 
(2) by striking ‘‘Director of Technology,’’ and in-
serting ‘‘Chief Scientist,’’. 
(b) ADDITIONAL RESPONSIBILITIES OF DIRECTOR.—
Section 708(c) (21 U.S.C. 1707(c)) is amended to read as 
follows: 
‘‘(c) ADDITIONAL RESPONSIBILITIES OF THE DIREC-
TOR OF NATIONAL DRUG CONTROL POLICY.—
‘‘(1) IN GENERAL.—The Director, acting through 
the Chief Scientist shall—
‘‘(A) identify and define the short-, me-
dium-, and long-term scientific and technological 
needs of Federal, State, and local law enforce-
ment agencies relating to drug enforcement, in-
cluding—
‘‘(i) advanced surveillance, tracking, 
and radar imaging; 
‘‘(ii) electronic support measures; 
‘‘(iii) communications;
‘‘(iv) data fusion, advanced computer 
systems, and artificial intelligence; and 
‘‘(v) chemical, biological, radiological 
(including neutron, electron, and graviton), 
and other means of detection; 
‘‘(B) identify demand reduction (including 
drug prevention) basic and applied research 
needs and initiatives, in consultation with af-
fected National Drug Control Program agencies, 
including—
‘‘(i) 
improving 
treatment 
through 
neuroscientific advances; 
‘‘(ii) improving the transfer of bio-
medical research to the clinical setting; and 
‘‘(iii) in consultation with the Na-
tional Institute on Drug Abuse and the 
Substance Abuse and Mental Health Serv-
ices Administration, and through inter-
agency agreements or grants, examining ad-
diction and rehabilitation research and the 
application of technology to expanding the 
effectiveness or availability of drug treat-
ment; 
‘‘(C) make a priority ranking of such needs 
identified in subparagraphs (A) and (B) accord-
ing to fiscal and technological feasibility, as part 
of a National Counter-Drug Enforcement Re-
search and Development Program; 
‘‘(D) oversee and coordinate counter-drug 
technology initiatives with related activities of 
other Federal civilian and military departments; 
‘‘(E) oversee and coordinate a technology 
transfer program for the transfer of technology to 
State and local law enforcement agencies; and 
‘‘(F) pursuant to the authority of the Direc-
tor of National Drug Control Policy under sec-
tion 704, submit requests to Congress for the re-
programming or transfer of funds appropriated 
for counter-drug technology research and develop-
ment. 
‘‘(2) 
PRIORITIES
IN
TRANSFERRING
TECH-
NOLOGY.—In transferring technology under the au-
thority of paragraph (1)(E), the Chief Scientist shall 
give priority, in transferring technologies most likely 
to assist in drug interdiction and border enforcement, 
to State, local, and tribal law enforcement agencies in 
southwest border areas and northern border areas 
with significant traffic in illicit drugs. 
‘‘(3) LIMITATION ON AUTHORITY.—The authority 
granted to the Director under this subsection shall not
extend to the award of contracts, management of indi-
vidual projects, or other operational activities.’’. 
(c) ASSISTANCE FROM SECRETARY OF HOMELAND SE-
CURITY.—Section 708(d) (21 U.S.C. 1707(d)) is amended 
by inserting ‘‘, the Secretary of Homeland Security,’’ after 
‘‘The Secretary of Defense’’. 
SEC. 9. REPEALS. 
The following provisions are repealed: 
(1) Sections 709 and 711 (21 U.S.C. 1708 and 
1710). 
(2) Section 6073 of the Asset Forfeiture Amend-
ments Act of 1988 (21 U.S.C. 1509). 
SEC. 10. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
(a) IN GENERAL.—The Act is further amended by in-
serting after section 708 the following: 
‘‘SEC. 709. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
‘‘(a) IN GENERAL.—The Director shall conduct a na-
tional media campaign in accordance with this section for 
the purpose of reducing and preventing illicit drug use 
among young people in the United States, through mass 
media advertising. 
‘‘(b) USE OF FUNDS.—
‘‘(1) IN GENERAL.—Amounts made available to 
carry out this section for the media campaign may 
only be used for the following:
‘‘(A) The purchase of media time and space. 
‘‘(B) Creative and talent costs. 
‘‘(C) Advertising production costs. 
‘‘(D) Testing and evaluation of advertising. 
‘‘(E) Evaluation of the effectiveness of the 
media campaign. 
‘‘(F) The negotiated fees for the winning 
bidder on requests for proposals issued either by 
the Office or its designee for purposes otherwise 
authorized in this section. 
‘‘(G) Partnerships with community, civic, 
and professional groups and government organi-
zations related to the media campaign. 
‘‘(H) Entertainment industry outreach, 
interactive outreach, media projects and activi-
ties, public information, news media outreach, 
and corporate sponsorship and participation. 
‘‘(I) Operational and management expenses. 
‘‘(2) SPECIFIC REQUIREMENTS.—
‘‘(A) CREATIVE SERVICES.—
‘‘(i) In using amounts for creative and 
talent costs under paragraph (1)(B), the Di-
rector shall use creative services donated at 
no cost to the Government wherever feasible
and may only procure creative services for 
advertising—
‘‘(I) responding to high-priority 
or emergent campaign needs that can-
not timely be obtained at no cost; or 
‘‘(II) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot reasonably be obtained at 
no cost. 
‘‘(ii) No more than $1,000,000 may be 
expended under this section each fiscal year 
on creative services, except that the Director 
may expend up to $2,000,000 in a fiscal 
year on creative services to meet urgent 
needs of the media campaign with advance 
approval from the Committee on Appro-
priations of the House of Representatives 
and of the Senate upon a showing of the 
circumstances causing such urgent needs of 
the media campaign. 
‘‘(B) TESTING AND EVALUATION OF ADVER-
TISING.—In using amounts for testing and eval-
uation of advertising under paragraph (1)(D), 
the Director shall test all advertisements prior to 
use in the media campaign to ensure that the
advertisements are effective and meet industry-
accepted standards. The Director may waive this 
requirement for advertisements using no more 
than 10 percent of the purchase of advertising 
time purchased under this section in an fiscal 
year and no more than 10 percent of the adver-
tising space purchased under this section in a 
fiscal year, if the advertisements respond to 
emergent and time-sensitive campaign needs or 
the advertisements will not be widely utilized in 
the media campaign. 
‘‘(C) EVALUATION
OF
EFFECTIVENESS
OF 
MEDIA
CAMPAIGN.—In using amounts for the 
evaluation of the effectiveness of the media cam-
paign under paragraph (1)(E), the Director 
shall—
‘‘(i) designate an independent entity to 
evaluate annually the effectiveness of the na-
tional media campaign based on data 
from—
‘‘(I) the ‘Monitoring the Future 
Study’ published by the Department of 
Health and Human Services;
‘‘(II) the Attitude Tracking Study 
published by the Partnership for a 
Drug Free America; 
‘‘(III) the National Household 
Survey on Drug Abuse; and 
‘‘(IV) other relevant studies or 
publications, as determined by the Di-
rector, including tracking and evalua-
tion data collected according to mar-
keting and advertising industry stand-
ards; and 
‘‘(ii) ensure that the effectiveness of the 
media campaign is evaluated in a manner 
that enables consideration of whether the 
media campaign has contributed to reduc-
tion of illicit drug use among youth and 
such other measures of evaluation as the Di-
rector determines are appropriate. 
‘‘(3) PURCHASE
OF
ADVERTISING
TIME
AND 
SPACE.—For each fiscal year, not less than 77 percent 
of the amounts appropriated under this section shall 
be used for the purchase of advertising time and space 
for the media campaign, subject to the following ex-
ceptions:
‘‘(A) In any fiscal year for which less than 
$125,000,000 is appropriated for the media cam-
paign, not less than 82 percent of the amounts 
appropriated under this section shall be used for 
the purchase of advertising time and space for 
the media campaign. 
‘‘(B) In any fiscal year for which more 
than $195,000,000 is appropriated under this 
section, not less than 72 percent shall be used for 
advertising production costs and the purchase of 
advertising time and space for the media cam-
paign. 
‘‘(c) ADVERTISING.—In carrying out this section, the 
Director shall devote sufficient funds to the advertising por-
tion of the national media campaign to meet the goals of 
the campaign. 
‘‘(d) PROHIBITIONS.—None of the amounts made 
available under subsection (b) may be obligated or expended 
for any of the following: 
‘‘(1) To supplant current antidrug community-
based coalitions. 
‘‘(2) To supplant pro bono public service time 
donated by national and local broadcasting networks 
for other public service campaigns.
‘‘(3) For partisan political purposes, or express 
advocacy in support of or to defeat any clearly identi-
fied candidate, clearly identified ballot initiative, or 
clearly identified legislative or regulatory proposal. 
‘‘(4) To fund advertising that features any elect-
ed officials, persons seeking elected office, cabinet level 
officials, or other Federal officials employed pursuant 
to section 213 of Schedule C of title 5, Code of Federal 
Regulations. 
‘‘(5) To fund advertising that does not contain 
a primary message intended to reduce or prevent il-
licit drug use. 
‘‘(6) To fund advertising containing a primary 
message intended to promote support for the media 
campaign or private sector contributions to the media 
campaign. 
‘‘(e) MATCHING REQUIREMENT.—
‘‘(1) IN
GENERAL.—Amounts made available 
under subsection (b) shall be matched by an equal 
amount of non-Federal funds for the media cam-
paign, or be matched with in-kind contributions of 
the same value. 
‘‘(2) NO-COST MATCH ADVERTISING DIRECT RE-
LATIONSHIP REQUIREMENT.—The Director shall en-
sure that at least 70 percent of no-cost match adver-
tising provided directly relates to substance abuse pre-
vention consistent with the specific purposes of the 
media campaign, except that in any fiscal year in 
which less than $125,000,000 is appropriated to the 
media campaign, the Director shall ensure that at 
least 85 percent of no-cost match advertising directly 
relates to substance abuse prevention consistent with 
the specific purposes of the media campaign. 
‘‘(3) NO-COST
MATCH
ADVERTISING
NOT
DI-
RECTLY
RELATED.—The Director shall ensure that 
no-cost match advertising that does not directly relate 
to substance abuse prevention includes a clear anti-
drug message. Such message is not required to be the 
primary message of the match advertising. 
‘‘(f) 
FINANCIAL
AND
PERFORMANCE
ACCOUNT-
ABILITY.—The Director shall cause to be performed—
‘‘(1) audits and reviews of costs of the media 
campaign pursuant to section 304C of the Federal 
Property and Administrative Services Act of 1949 (41 
U.S.C. 254d); and 
‘‘(2) an audit of the cost of the media campaign 
described in section 306 of such Act (41 U.S.C. 256). 
‘‘(g) STRATEGIC GUIDANCE
AND DONATIONS.—The 
Partnership for a Drug Free America shall serve as the pri-
mary outside strategic advisor to the media campaign and
be responsible for coordinating donations of creative and 
other services to the campaign, except with respect to adver-
tising created using funds permitted in subsection (b). The 
Director shall inform the Partnership for a Drug Free 
America of the strategic goals of the campaign and consider 
advice from the Partnership for a Drug Free America on 
media campaign strategy. 
‘‘(h) REPORT TO CONGRESS.—The Director shall sub-
mit on an annual basis a report to Congress that de-
scribes—
‘‘(1) the strategy of the media campaign and 
whether specific objectives of the media campaign 
were accomplished; 
‘‘(2) steps taken to ensure that the media cam-
paign operates in an effective and efficient manner 
consistent with the overall strategy and focus of the 
media campaign; 
‘‘(3) plans to purchase advertising time and 
space; 
‘‘(4) policies and practices implemented to en-
sure that Federal funds are used responsibly to pur-
chase advertising time and space and eliminate the 
potential for waste, fraud, and abuse; and
‘‘(5) all contracts entered into with a corpora-
tion, partnership, or individual working on behalf of 
the media campaign. 
‘‘(i) LOCAL TARGET REQUIREMENT.—The Director 
shall, to the maximum extent feasible, use amounts made 
available under this section for media that focuses on, or 
includes specific information on, prevention or treatment 
resources for consumers within specific local areas. 
‘‘(j) PREVENTION OF MARIJUANA USE.—
‘‘(1) FINDINGS.—The Congress finds the fol-
lowing: 
‘‘(A) 60 percent of adolescent admissions for 
drug treatment are based on marijuana use. 
‘‘(B) Potency levels of contemporary mari-
juana, particularly hydroponically grown mari-
juana, are significantly higher than in the past, 
rising from under 1 percent of THC in the mid-
1970s to as high as 30 percent today. 
‘‘(C) Contemporary research has dem-
onstrated that youths smoking marijuana early 
in life may be up to five times more likely to use 
hard drugs. 
‘‘(D) Contemporary research has dem-
onstrated clear detrimental effects in adolescent
educational achievement resulting from mari-
juana use. 
‘‘(E) Contemporary research has dem-
onstrated clear detrimental effects in adolescent 
brain development resulting from marijuana use. 
‘‘(F) An estimated 9,000,000 Americans a 
year drive while under the influence of illegal 
drugs, including marijuana. 
‘‘(G) Marijuana smoke contains 50 to 70 
percent more of certain cancer causing chemicals 
than tobacco smoke. 
‘‘(H) Teens who use marijuana are up to 
four times more likely to have a teen pregnancy 
than teens who have not. 
‘‘(I) Federal law enforcement agencies have 
identified clear links suggesting that trade in hy-
droponic marijuana facilitates trade by criminal 
organizations in hard drugs, including heroin. 
‘‘(J) Federal law enforcement agencies have 
identified possible links between trade in mari-
juana and financing for terrorist organizations. 
‘‘(2) EMPHASIS ON PREVENTION OF YOUTH MARI-
JUANA USE.—In conducting advertising and activities 
otherwise authorized under this section, the Director 
may emphasize prevention of youth marijuana use.
‘‘(k) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to the Office to carry out this 
section, $195,000,000 for each of fiscal years 2004 and 2005 
and $210,000,000 for each of fiscal years 2006 through 
2008.’’. 
(b) REPEAL
OF
SUPERSEDED
PROVISIONS.—The 
Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 
et seq.) is repealed. 
SEC. 11. AUTHORIZATION OF APPROPRIATIONS. 
Section 714 (21 U.S.C. 1711) is amended—
(1) by striking ‘‘title,’’ and inserting ‘‘title, ex-
cept activities for which amounts are otherwise spe-
cifically authorized by this title,’’; and 
(2) by striking ‘‘1999 through 2003’’ and insert-
ing ‘‘2004 through 2008’’. 
SEC. 12. EXTENSION OF TERMINATION DATE. 
Section 715(a) is amended by striking ‘‘September 30, 
2003, this title and the amendments made by this title are 
repealed’’ and inserting ‘‘September 30, 2008, this title is 
repealed’’.
SECTION 1. SHORT TITLE; REFERENCES; TABLE OF CON-
TENTS. 
(a) SHORT TITLE.—This Act may be cited as 
the ‘‘Office of National Drug Control Policy 
Reauthorization Act of 2003’’.
(b) AMENDMENT
OF OFFICE
OF NATIONAL 
DRUG CONTROL POLICY REAUTHORIZATION ACT 
OF 1998.—Except as otherwise expressly pro-
vided, whenever in this Act an amendment or 
repeal is expressed in terms of an amendment 
to, or repeal of, a section or other provision, 
the reference shall be considered to be made 
to a section or other provision of the Office 
of National Drug Control Policy Reauthoriza-
tion Act of 1998 (Public Law 105–277; 21 U.S.C. 
1701 et seq.). 
(c) TABLE OF CONTENTS.—The table of con-
tents of this Act is as follows:
Sec. 1. Short title; references; table of contents. 
Sec. 2. Amendments to definitions. 
Sec. 3. Amendments relating to appointment and duties of Di-
rector and Deputy Directors. 
Sec. 4. Amendments relating to coordination with other agen-
cies. 
Sec. 5. Development, submission, implementation, and assess-
ment of National Drug Control Strategy. 
Sec. 6. High intensity drug trafficking areas program. 
Sec. 7. Funding for certain high intensity drug trafficking 
areas. 
Sec. 8. Amendments relating to Counter-Drug Technology As-
sessment Center. 
Sec. 9. Repeals. 
Sec. 10. National Youth Antidrug Media Campaign. 
Sec. 11. Authorization of appropriations. 
Sec. 12. Extension of termination date.
SEC. 2. AMENDMENTS TO DEFINITIONS. 
(a) AMENDMENTS TO DEFINITIONS.—Section 
702 (21 U.S.C. 1701) is amended—
(1) in paragraph (1)—
(A) by striking ‘‘and’’ at the end of 
subparagraph (F); 
(B) by striking the period at the 
end of subparagraph (G) and insert-
ing a semicolon; and 
(C) by adding at the end the fol-
lowing: 
‘‘(H) interventions for drug abuse 
and dependence; and 
‘‘(I) international drug control co-
ordination and cooperation with re-
spect to activities described in this 
paragraph.’’. 
(2) in paragraph (9), by striking ‘‘im-
plicates’’ and inserting ‘‘indicates’’; 
(3) in paragraph (10)—
(A) by striking ‘‘and’’ at the end of 
subparagraph (B); 
(B) by striking the period at the 
end of subparagraph (C) and insert-
ing ‘‘; and’’; and 
(C) by adding at the end the fol-
lowing:
‘‘(D) domestic drug law enforce-
ment, including law enforcement di-
rected at drug users.’’; and 
(4) in paragraph (11)—
(A) by inserting before the semi-
colon in subparagraph (A) the fol-
lowing: ‘‘(including source country 
programs, and law enforcement out-
side the United States)’’; 
(B) by inserting ‘‘and’’ after the 
semicolon in subparagraph (B); 
(C) by striking ‘‘; and’’ at the end 
of subparagraph (C) and inserting a 
period; and 
(D) by striking subparagraph (D). 
(b) 
CONFORMING
AMENDMENTS.—Section 
703(b)(3) (21 U.S.C. 1702(b)(3)) is amended—
(1) in subparagraph (A), by striking 
‘‘(G)’’ and inserting ‘‘(H)’’; and 
(2) in subparagraph (C)—
(A) by striking ‘‘(C)’’ and inserting 
‘‘(D)’’; and 
(B) by striking ‘‘and subpara-
graph (D) of section 702(11)’’.
SEC. 3. AMENDMENTS RELATING TO APPOINTMENT AND 
DUTIES OF DIRECTOR AND DEPUTY DIREC-
TORS. 
(a) DESIGNATION OF OTHER OFFICERS.—Sec-
tion 704(a)(3) (21 U.S.C. 1703(a)(3)) is amend-
ed—
(1) by striking ‘‘permanent employee’’ 
and inserting ‘‘officer or employee’’; and 
(2) by striking ‘‘serve as the Director’’ 
and inserting ‘‘serve as the acting Direc-
tor’’. 
(b) RESPONSIBILITIES
OF DIRECTOR.—Sec-
tion 704(b) (21 U.S.C. 1703(b)) is amended—
(1) in paragraph (4), by striking ‘‘Fed-
eral departments and agencies engaged 
in drug enforcement,’’ and inserting ‘‘Na-
tional Drug Control Program agencies,’’; 
(2) by inserting ‘‘and’’ at the end of 
paragraph (12); 
(3) by striking paragraphs (13) and 
(14); and 
(4) by redesignating paragraph (15) as 
paragraph (13). 
(c) REVIEW AND CERTIFICATION OF NATIONAL 
DRUG
CONTROL
PROGRAM
BUDGET.—Section 
704(c)(3) (21 U.S.C. 1703(c)(3)) is amended—
(1) by redesignating subparagraphs 
(C) and (D) as subparagraphs (D) and (E), 
respectively; 
(2) by inserting after subparagraph 
(B) the following new subparagraph: 
‘‘(C) SPECIFIC
REQUESTS.—The Di-
rector shall not confirm the adequacy 
of any budget request that—
‘‘(i) requests funding for Fed-
eral law enforcement activities 
that 
do 
not 
adequately 
com-
pensate for transfers of drug en-
forcement 
resources 
and 
per-
sonnel to law enforcement and in-
vestigation activities not related 
to drug enforcement as deter-
mined by the Director; 
‘‘(ii) requests funding for law 
enforcement activities on the bor-
ders of the United States that do 
not adequately direct resources to 
drug interdiction and enforce-
ment as determined by the Direc-
tor;
‘‘(iii) 
requests 
funding 
for 
drug treatment activities that do 
not provide adequate result and 
accountability measures as deter-
mined by the Director; 
‘‘(iv) requests funding for any 
activities of the Safe and Drug 
Free Schools Program that do not 
include a clear antidrug message 
or purpose intended to reduce 
drug use; 
‘‘(v) requests funding to en-
force section 484(r)(1) of the High-
er Education Act of 1965 (20 
U.S.C. 1091(r)(1)) with respect to 
convictions for drug-related of-
fenses not occurring during a pe-
riod of enrollment for which the 
student was receiving any Fed-
eral grant, loan, or work assist-
ance;
‘‘(vi) 
requests 
funding 
for 
drug treatment activities that do 
not adequately support and en-
hance Federal drug treatment
programs and capacity, as deter-
mined by the Director; or 
‘‘(vii) requests funding for fis-
cal year 2005 for activities of the 
Department of Education, unless 
it is accompanied by a report set-
ting forth a plan for providing ex-
pedited consideration of student 
loan applications for all individ-
uals who submitted an applica-
tion for any Federal grant, loan, 
or work assistance that was re-
jected or denied pursuant to sec-
tion 484(r)(1) of the Higher Edu-
cation Act of 1965 (20 U.S.C. 
1091(r)(1)) by reason of a convic-
tion for a drug-related offense not 
occurring during a period of en-
rollment for which the individual 
was receiving any Federal grant, 
loan, or work assistance.’’; 
(3) in subparagraph (D)(iii), as so re-
designated, by inserting ‘‘and the author-
izing committees of Congress for the Of-
fice’’ after ‘‘House of Representatives’’; 
and 
(4) in subparagraph (E)(ii)(II)(bb), as 
so redesignated, by inserting ‘‘and the au-
thorizing committees of Congress for the 
Office’’ after ‘‘House of Representatives’’. 
(d) REPROGRAMMING
AND
TRANSFER
RE-
QUESTS.—Section 
704(c)(4)(A) 
(21 
U.S.C. 
1703(c)(4)(A)) 
is 
amended 
by 
striking 
‘‘$5,000,000’’ and inserting ‘‘$1,000,000’’. 
(e) POWERS OF DIRECTOR.—Section 704(d) 
(21 U.S.C. 1703(d)) is amended—
(1) in paragraph (8)(D), by striking 
‘‘have been authorized by Congress;’’ and 
inserting ‘‘authorized by law;’’; 
(2) in paragraph (9)—
(A) by inserting ‘‘notwithstanding 
any other provision of law,’’ after 
‘‘(9)’’; and 
(B) by striking ‘‘Strategy; and’’ 
and inserting ‘‘Strategy and notify 
the authorizing Committees of Con-
gress for the Office of any fund con-
trol notice issued;’’;
‘‘(ii) electronic support meas-
ures; 
‘‘(iii) communications; 
‘‘(iv) data fusion, advanced 
computer systems, and artificial 
intelligence; and 
‘‘(v) chemical, biological, radi-
ological (including neutron, elec-
tron, and graviton), and other 
means of detection; 
‘‘(B) identify demand reduction 
(including drug prevention) basic and 
applied research needs and initia-
tives, in consultation with affected 
National Drug Control Program agen-
cies, including—
‘‘(i) 
improving 
treatment 
through neuroscientific advances; 
‘‘(ii) improving the transfer of 
biomedical research to the clin-
ical setting; and 
‘‘(iii) in consultation with the 
National Institute on Drug Abuse 
and the Substance Abuse and 
Mental Health Services Adminis-